

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell adhesion mediated by integrin (GO:0033627) | 5.50822306 |
| 2 | axonemal dynein complex assembly (GO:0070286) | 4.54967246 |
| 3 | protein localization to endosome (GO:0036010) | 4.20196775 |
| 4 | skin morphogenesis (GO:0043589) | 4.17919489 |
| 5 | vocalization behavior (GO:0071625) | 4.07348854 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 3.93532710 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 3.93532710 |
| 8 | hemidesmosome assembly (GO:0031581) | 3.82182163 |
| 9 | locomotory exploration behavior (GO:0035641) | 3.81595823 |
| 10 | kidney mesenchyme development (GO:0072074) | 3.64505309 |
| 11 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.50983342 |
| 12 | apoptotic cell clearance (GO:0043277) | 3.49741301 |
| 13 | substrate-dependent cell migration (GO:0006929) | 3.45608983 |
| 14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.43945004 |
| 15 | hypotonic response (GO:0006971) | 3.43102313 |
| 16 | metanephric mesenchyme development (GO:0072075) | 3.38712049 |
| 17 | endodermal cell differentiation (GO:0035987) | 3.32981937 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 3.32229541 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29269529 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.28496623 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 3.28000898 |
| 22 | collagen fibril organization (GO:0030199) | 3.24780997 |
| 23 | iron ion import (GO:0097286) | 3.20603990 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.20219573 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.19060694 |
| 26 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.19026148 |
| 27 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.12506378 |
| 28 | surfactant homeostasis (GO:0043129) | 3.11670310 |
| 29 | protein localization to synapse (GO:0035418) | 3.11219927 |
| 30 | positive regulation of extracellular matrix organization (GO:1903055) | 3.07487709 |
| 31 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.06834682 |
| 32 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.06750178 |
| 33 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.04577789 |
| 34 | exploration behavior (GO:0035640) | 3.04350493 |
| 35 | mating behavior (GO:0007617) | 3.02113191 |
| 36 | cellular response to vitamin D (GO:0071305) | 3.02068418 |
| 37 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.01669887 |
| 38 | chondrocyte proliferation (GO:0035988) | 3.00719878 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.99092421 |
| 40 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.98549265 |
| 41 | protein retention in ER lumen (GO:0006621) | 2.98241138 |
| 42 | synaptic vesicle maturation (GO:0016188) | 2.97265906 |
| 43 | wound healing, spreading of epidermal cells (GO:0035313) | 2.97098419 |
| 44 | cilium movement (GO:0003341) | 2.96004240 |
| 45 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.95664890 |
| 46 | proline transport (GO:0015824) | 2.95632673 |
| 47 | chemical homeostasis within a tissue (GO:0048875) | 2.95267381 |
| 48 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.92323448 |
| 49 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.91017558 |
| 50 | glomerular epithelial cell development (GO:0072310) | 2.87183792 |
| 51 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.85973254 |
| 52 | positive regulation of vesicle fusion (GO:0031340) | 2.83603182 |
| 53 | desmosome organization (GO:0002934) | 2.83199308 |
| 54 | striatum development (GO:0021756) | 2.82895747 |
| 55 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.81764329 |
| 56 | neuron recognition (GO:0008038) | 2.81514198 |
| 57 | layer formation in cerebral cortex (GO:0021819) | 2.81348784 |
| 58 | neurotransmitter secretion (GO:0007269) | 2.79170548 |
| 59 | glomerular basement membrane development (GO:0032836) | 2.78259473 |
| 60 | regulation of synapse structural plasticity (GO:0051823) | 2.77609256 |
| 61 | mesodermal cell differentiation (GO:0048333) | 2.76307038 |
| 62 | COPII vesicle coating (GO:0048208) | 2.76205302 |
| 63 | adhesion of symbiont to host cell (GO:0044650) | 2.76119845 |
| 64 | virion attachment to host cell (GO:0019062) | 2.76119845 |
| 65 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.75945366 |
| 66 | barbed-end actin filament capping (GO:0051016) | 2.75832748 |
| 67 | motile cilium assembly (GO:0044458) | 2.73639244 |
| 68 | epithelial cell-cell adhesion (GO:0090136) | 2.72516681 |
| 69 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.72050880 |
| 70 | cellular response to vitamin (GO:0071295) | 2.71840887 |
| 71 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.70877244 |
| 72 | membrane raft organization (GO:0031579) | 2.69478342 |
| 73 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.69160139 |
| 74 | negative regulation of anoikis (GO:2000811) | 2.66517787 |
| 75 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.64934383 |
| 76 | regulation of synaptic vesicle transport (GO:1902803) | 2.63648133 |
| 77 | cell-substrate junction assembly (GO:0007044) | 2.63328567 |
| 78 | glutamate receptor signaling pathway (GO:0007215) | 2.62765580 |
| 79 | collagen metabolic process (GO:0032963) | 2.60980900 |
| 80 | cellular potassium ion homeostasis (GO:0030007) | 2.60700869 |
| 81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.60035364 |
| 82 | positive regulation of protein autophosphorylation (GO:0031954) | 2.59507735 |
| 83 | import into cell (GO:0098657) | 2.58775726 |
| 84 | axonal fasciculation (GO:0007413) | 2.58593071 |
| 85 | regulation of beta-amyloid formation (GO:1902003) | 2.57479540 |
| 86 | long-term synaptic potentiation (GO:0060291) | 2.55866025 |
| 87 | regulation of mononuclear cell migration (GO:0071675) | 2.55769886 |
| 88 | regulation of vesicle fusion (GO:0031338) | 2.55210723 |
| 89 | extracellular negative regulation of signal transduction (GO:1900116) | 2.53948808 |
| 90 | extracellular regulation of signal transduction (GO:1900115) | 2.53948808 |
| 91 | regulation of metalloenzyme activity (GO:0048552) | 2.53288507 |
| 92 | synaptic transmission, dopaminergic (GO:0001963) | 2.53022261 |
| 93 | collagen catabolic process (GO:0030574) | 2.52806981 |
| 94 | transmission of nerve impulse (GO:0019226) | 2.52657887 |
| 95 | wound healing, spreading of cells (GO:0044319) | 2.52481323 |
| 96 | cellular copper ion homeostasis (GO:0006878) | 2.52079293 |
| 97 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.51041339 |
| 98 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.50431661 |
| 99 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.50412098 |
| 100 | gamma-aminobutyric acid transport (GO:0015812) | 2.49177023 |
| 101 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.49017525 |
| 102 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.48186141 |
| 103 | glutamate secretion (GO:0014047) | 2.47541854 |
| 104 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47431145 |
| 105 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.46807954 |
| 106 | muscle cell migration (GO:0014812) | 2.46092393 |
| 107 | membrane protein ectodomain proteolysis (GO:0006509) | 2.45507500 |
| 108 | neuron-neuron synaptic transmission (GO:0007270) | 2.45477044 |
| 109 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.44160574 |
| 110 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.44035023 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.43529636 |
| 112 | extracellular matrix disassembly (GO:0022617) | 2.42861056 |
| 113 | response to vitamin D (GO:0033280) | 2.42636319 |
| 114 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.42507040 |
| 115 | axon extension involved in axon guidance (GO:0048846) | 2.42507040 |
| 116 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.42505792 |
| 117 | postsynaptic membrane organization (GO:0001941) | 2.42338793 |
| 118 | positive regulation of osteoblast proliferation (GO:0033690) | 2.42100890 |
| 119 | stress fiber assembly (GO:0043149) | 2.41958753 |
| 120 | regulation of early endosome to late endosome transport (GO:2000641) | 2.41222737 |
| 121 | vesicle coating (GO:0006901) | 2.41107884 |
| 122 | keratan sulfate catabolic process (GO:0042340) | 2.40739886 |
| 123 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.40737152 |
| 124 | regulation of glutamate secretion (GO:0014048) | 2.40622055 |
| 125 | vesicle transport along microtubule (GO:0047496) | 2.40296562 |
| 126 | macroautophagy (GO:0016236) | 2.39481875 |
| 127 | endocytic recycling (GO:0032456) | 2.39262974 |
| 128 | dendritic spine morphogenesis (GO:0060997) | 2.38812071 |
| 129 | chondrocyte development (GO:0002063) | 2.38796377 |
| 130 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.37988738 |
| 131 | oligosaccharide catabolic process (GO:0009313) | 2.37691350 |
| 132 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.36981853 |
| 133 | adhesion of symbiont to host (GO:0044406) | 2.36891224 |
| 134 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.36750421 |
| 135 | synapse assembly (GO:0007416) | 2.36731575 |
| 136 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.36688153 |
| 137 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.36464895 |
| 138 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.36145362 |
| 139 | neuronal action potential propagation (GO:0019227) | 2.35810505 |
| 140 | long-term memory (GO:0007616) | 2.35560532 |
| 141 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.35443362 |
| 142 | left/right pattern formation (GO:0060972) | 2.35182415 |
| 143 | regulation of postsynaptic membrane potential (GO:0060078) | 2.34514146 |
| 144 | multicellular organismal metabolic process (GO:0044236) | 2.33936232 |
| 145 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.33292446 |
| 146 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.32599779 |
| 147 | prepulse inhibition (GO:0060134) | 2.32375777 |
| 148 | response to auditory stimulus (GO:0010996) | 2.32237935 |
| 149 | negative regulation of amino acid transport (GO:0051956) | 2.31754286 |
| 150 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.31450548 |
| 151 | response to histamine (GO:0034776) | 2.30643518 |
| 152 | synaptic transmission, glutamatergic (GO:0035249) | 2.29930392 |
| 153 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.29373598 |
| 154 | apical protein localization (GO:0045176) | 2.28319573 |
| 155 | regulation of synaptic plasticity (GO:0048167) | 2.28203413 |
| 156 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.27512371 |
| 157 | multicellular organismal catabolic process (GO:0044243) | 2.26761654 |
| 158 | establishment of tissue polarity (GO:0007164) | 2.26535758 |
| 159 | establishment of planar polarity (GO:0001736) | 2.26535758 |
| 160 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.26465065 |
| 161 | phagosome maturation (GO:0090382) | 2.25614863 |
| 162 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.25569222 |
| 163 | neurotransmitter transport (GO:0006836) | 2.24354949 |
| 164 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.24002007 |
| 165 | multi-organism reproductive behavior (GO:0044705) | 2.23985993 |
| 166 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.23908827 |
| 167 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.23816320 |
| 168 | glycosphingolipid catabolic process (GO:0046479) | 2.22669734 |
| 169 | extracellular fibril organization (GO:0043206) | 2.22283271 |
| 170 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.22186026 |
| 171 | dendrite morphogenesis (GO:0048813) | 2.22113733 |
| 172 | reproductive behavior (GO:0019098) | 2.20700100 |
| 173 | activation of protein kinase A activity (GO:0034199) | 2.20513601 |
| 174 | neuromuscular process controlling balance (GO:0050885) | 2.19946367 |
| 175 | negative regulation of dendrite development (GO:2000171) | 2.19266451 |
| 176 | response to amphetamine (GO:0001975) | 2.15896444 |
| 177 | negative regulation of amine transport (GO:0051953) | 2.15847099 |
| 178 | transferrin transport (GO:0033572) | 2.14131676 |
| 179 | behavioral response to cocaine (GO:0048148) | 2.13032971 |
| 180 | suckling behavior (GO:0001967) | 2.12925468 |
| 181 | synaptic vesicle endocytosis (GO:0048488) | 2.12833416 |
| 182 | regulation of neurotransmitter levels (GO:0001505) | 2.11565592 |
| 183 | startle response (GO:0001964) | 2.11355864 |
| 184 | alanine transport (GO:0032328) | 2.09569037 |
| 185 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.09566986 |
| 186 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.08852638 |
| 187 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.08705845 |
| 188 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.08705845 |
| 189 | detection of calcium ion (GO:0005513) | 2.07699034 |
| 190 | regulation of cellular amide metabolic process (GO:0034248) | 2.06961025 |
| 191 | learning (GO:0007612) | 2.05984186 |
| 192 | presynaptic membrane assembly (GO:0097105) | 2.05612793 |
| 193 | ferric iron transport (GO:0015682) | 2.04440323 |
| 194 | trivalent inorganic cation transport (GO:0072512) | 2.04440323 |
| 195 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.04381481 |
| 196 | auditory behavior (GO:0031223) | 2.03770150 |
| 197 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.03665553 |
| 198 | regulation of dendritic spine development (GO:0060998) | 2.03380287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.29617286 |
| 2 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.67493038 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.62294949 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.85044018 |
| 5 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.84532321 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68677983 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60327343 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.41588271 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.40515229 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.35808406 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34538501 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29303278 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23768701 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.22404339 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21428738 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.19334371 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.19334371 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.19105063 |
| 19 | CJUN_26792858_Chip-Seq_BT549_Human | 2.18964021 |
| 20 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.15873969 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.14617284 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09266850 |
| 23 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.07380451 |
| 24 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.07380451 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07337217 |
| 26 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.01944015 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01406212 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.94504103 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.85012058 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84235299 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83827593 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.83747053 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82752204 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82710646 |
| 35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.82508038 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76980583 |
| 37 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.76773419 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75811353 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.74024736 |
| 40 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.73922742 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70504727 |
| 42 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.69933957 |
| 43 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69607439 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69458746 |
| 45 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68620910 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.65955925 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.65341621 |
| 48 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60682076 |
| 49 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60551485 |
| 50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.60457921 |
| 51 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59595832 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59461184 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58118353 |
| 54 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58022031 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57795913 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57565571 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57467001 |
| 58 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.57058947 |
| 59 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.56963430 |
| 60 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.56205917 |
| 61 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.53946057 |
| 62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.53420146 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51522132 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51522132 |
| 65 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.49885641 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.49579595 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47086663 |
| 68 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.44766023 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.43219287 |
| 70 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.42739945 |
| 71 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.42507436 |
| 72 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41837782 |
| 73 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.41023934 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40374745 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39197512 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38384730 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37493016 |
| 78 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.36770292 |
| 79 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36657964 |
| 80 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36354907 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35299284 |
| 82 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35297804 |
| 83 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35171608 |
| 84 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33497767 |
| 85 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33412066 |
| 86 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32285147 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30984281 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28837755 |
| 89 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28821838 |
| 90 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.28709864 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.28304636 |
| 92 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28014758 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27965837 |
| 94 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27869453 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26604676 |
| 96 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26322373 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25232660 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24897180 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.24542698 |
| 100 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23995922 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21605667 |
| 102 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21327931 |
| 103 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21054738 |
| 104 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20892745 |
| 105 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19744514 |
| 106 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19470783 |
| 107 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17916545 |
| 108 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14820094 |
| 109 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13432353 |
| 110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12971338 |
| 111 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11968327 |
| 112 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11904363 |
| 113 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11825867 |
| 114 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11152302 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10712643 |
| 116 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10090961 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09595615 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08772759 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07510846 |
| 120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07510846 |
| 121 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07376194 |
| 122 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07207081 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06728286 |
| 124 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.06370195 |
| 125 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05708080 |
| 126 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05264839 |
| 127 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05264209 |
| 128 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04324577 |
| 129 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04245622 |
| 130 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04127041 |
| 131 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03783096 |
| 132 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.03649397 |
| 133 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03142079 |
| 134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02852388 |
| 135 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00164826 |
| 136 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98585862 |
| 137 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97551027 |
| 138 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96721083 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96075924 |
| 140 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95986033 |
| 141 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95582232 |
| 142 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95563508 |
| 143 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95349396 |
| 144 | AR_19668381_ChIP-Seq_PC3_Human | 0.94813685 |
| 145 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94791345 |
| 146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94159957 |
| 147 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93892193 |
| 148 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92736677 |
| 149 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92704917 |
| 150 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92638964 |
| 151 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.91858478 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91047492 |
| 153 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90880893 |
| 154 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90783515 |
| 155 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90709052 |
| 156 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90646997 |
| 157 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90588687 |
| 158 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90410217 |
| 159 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.90407549 |
| 160 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88577541 |
| 161 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87960361 |
| 162 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87630492 |
| 163 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86913651 |
| 164 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.86831936 |
| 165 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86016392 |
| 166 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85566066 |
| 167 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.84871141 |
| 168 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83353610 |
| 169 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81916971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.53249131 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.22245100 |
| 3 | MP0002822_catalepsy | 3.71527449 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.58690759 |
| 5 | MP0005623_abnormal_meninges_morphology | 3.57306518 |
| 6 | MP0003880_abnormal_central_pattern | 3.53983599 |
| 7 | MP0005257_abnormal_intraocular_pressure | 3.11330015 |
| 8 | MP0003566_abnormal_cell_adhesion | 3.05688821 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 3.04246785 |
| 10 | MP0004272_abnormal_basement_membrane | 2.91780243 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.86936119 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.83028312 |
| 13 | MP0009745_abnormal_behavioral_response | 2.77605159 |
| 14 | MP0005275_abnormal_skin_tensile | 2.75236600 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.72604523 |
| 16 | MP0003091_abnormal_cell_migration | 2.63044117 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.58561815 |
| 18 | MP0003941_abnormal_skin_development | 2.55728383 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.49895178 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.46956685 |
| 21 | MP0003279_aneurysm | 2.44711922 |
| 22 | MP0004270_analgesia | 2.42329096 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.41600400 |
| 24 | MP0002064_seizures | 2.41068068 |
| 25 | MP0006054_spinal_hemorrhage | 2.34521855 |
| 26 | MP0005023_abnormal_wound_healing | 2.24742992 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 2.24614825 |
| 28 | MP0009046_muscle_twitch | 2.23755565 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 2.19613845 |
| 30 | MP0001968_abnormal_touch/_nociception | 2.17535714 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 2.11961422 |
| 32 | MP0004858_abnormal_nervous_system | 2.08935593 |
| 33 | MP0002735_abnormal_chemical_nociception | 2.02459980 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.96637787 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.95541456 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.85897790 |
| 37 | MP0002896_abnormal_bone_mineralization | 1.84177110 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.84022720 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.82162385 |
| 40 | MP0002060_abnormal_skin_morphology | 1.81012272 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.80417739 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.79077055 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.78364114 |
| 44 | MP0000604_amyloidosis | 1.75521781 |
| 45 | MP0001177_atelectasis | 1.71959580 |
| 46 | MP0003329_amyloid_beta_deposits | 1.70194395 |
| 47 | MP0002736_abnormal_nociception_after | 1.67783281 |
| 48 | MP0001542_abnormal_bone_strength | 1.67230084 |
| 49 | MP0001486_abnormal_startle_reflex | 1.59734081 |
| 50 | MP0001970_abnormal_pain_threshold | 1.59070904 |
| 51 | MP0009840_abnormal_foam_cell | 1.57933087 |
| 52 | MP0002272_abnormal_nervous_system | 1.57090085 |
| 53 | MP0003690_abnormal_glial_cell | 1.56316960 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.55179791 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.54219054 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.48755552 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.48330876 |
| 58 | MP0005083_abnormal_biliary_tract | 1.45402378 |
| 59 | MP0001958_emphysema | 1.41964456 |
| 60 | MP0003303_peritoneal_inflammation | 1.40613587 |
| 61 | MP0003075_altered_response_to | 1.38884590 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.36897056 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.36824934 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.36138659 |
| 65 | MP0000733_abnormal_muscle_development | 1.34713646 |
| 66 | MP0005508_abnormal_skeleton_morphology | 1.33306432 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.32339050 |
| 68 | MP0002254_reproductive_system_inflammat | 1.30716684 |
| 69 | MP0009384_cardiac_valve_regurgitation | 1.30497944 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.30249140 |
| 71 | MP0002139_abnormal_hepatobiliary_system | 1.29746025 |
| 72 | MP0002168_other_aberrant_phenotype | 1.26778758 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.26712517 |
| 74 | MP0002090_abnormal_vision | 1.26186425 |
| 75 | MP0010030_abnormal_orbit_morphology | 1.25079457 |
| 76 | MP0000778_abnormal_nervous_system | 1.24923547 |
| 77 | MP0004924_abnormal_behavior | 1.23572568 |
| 78 | MP0005386_behavior/neurological_phenoty | 1.23572568 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 1.21718760 |
| 80 | * MP0002184_abnormal_innervation | 1.18933142 |
| 81 | MP0003122_maternal_imprinting | 1.17239945 |
| 82 | MP0005165_increased_susceptibility_to | 1.15704911 |
| 83 | MP0003448_altered_tumor_morphology | 1.15460644 |
| 84 | MP0000383_abnormal_hair_follicle | 1.14869318 |
| 85 | MP0005166_decreased_susceptibility_to | 1.11964725 |
| 86 | MP0003633_abnormal_nervous_system | 1.11937825 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 1.11911743 |
| 88 | MP0005388_respiratory_system_phenotype | 1.10328523 |
| 89 | MP0002133_abnormal_respiratory_system | 1.10328523 |
| 90 | MP0004510_myositis | 1.09702711 |
| 91 | MP0001243_abnormal_dermal_layer | 1.06626314 |
| 92 | MP0001984_abnormal_olfaction | 1.04581374 |
| 93 | MP0008569_lethality_at_weaning | 1.04468556 |
| 94 | MP0004811_abnormal_neuron_physiology | 1.03723397 |
| 95 | MP0005646_abnormal_pituitary_gland | 1.03477416 |
| 96 | MP0006082_CNS_inflammation | 1.02825928 |
| 97 | MP0005197_abnormal_uvea_morphology | 1.02146648 |
| 98 | MP0002876_abnormal_thyroid_physiology | 1.01598649 |
| 99 | MP0001849_ear_inflammation | 1.01595611 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.98578066 |
| 101 | MP0005595_abnormal_vascular_smooth | 0.98379848 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.97282765 |
| 103 | MP0003283_abnormal_digestive_organ | 0.94431315 |
| 104 | MP0002282_abnormal_trachea_morphology | 0.93912961 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.93875130 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.93112807 |
| 107 | MP0003634_abnormal_glial_cell | 0.92816314 |
| 108 | MP0009053_abnormal_anal_canal | 0.91591002 |
| 109 | MP0003631_nervous_system_phenotype | 0.90732072 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.90139678 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.88348635 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.88037633 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.87970303 |
| 114 | MP0000858_altered_metastatic_potential | 0.86903319 |
| 115 | MP0002066_abnormal_motor_capabilities/c | 0.85366539 |
| 116 | MP0005164_abnormal_response_to | 0.85144943 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.85085123 |
| 118 | MP0005193_abnormal_anterior_eye | 0.85019602 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.84741150 |
| 120 | MP0001879_abnormal_lymphatic_vessel | 0.84013605 |
| 121 | MP0004885_abnormal_endolymph | 0.83841781 |
| 122 | MP0001915_intracranial_hemorrhage | 0.82946597 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.82101790 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.81914697 |
| 125 | MP0003868_abnormal_feces_composition | 0.81875736 |
| 126 | MP0001664_abnormal_digestion | 0.81861251 |
| 127 | MP0000343_altered_response_to | 0.81646094 |
| 128 | * MP0002882_abnormal_neuron_morphology | 0.81438613 |
| 129 | MP0005379_endocrine/exocrine_gland_phen | 0.80574401 |
| 130 | MP0003879_abnormal_hair_cell | 0.79636952 |
| 131 | MP0001188_hyperpigmentation | 0.79475447 |
| 132 | MP0005535_abnormal_body_temperature | 0.79431355 |
| 133 | MP0005310_abnormal_salivary_gland | 0.79110792 |
| 134 | MP0005390_skeleton_phenotype | 0.78523794 |
| 135 | MP0008004_abnormal_stomach_pH | 0.77237727 |
| 136 | MP0000681_abnormal_thyroid_gland | 0.77078146 |
| 137 | MP0004883_abnormal_blood_vessel | 0.76649410 |
| 138 | MP0009250_abnormal_appendicular_skeleto | 0.76039015 |
| 139 | * MP0000955_abnormal_spinal_cord | 0.75976844 |
| 140 | MP0002113_abnormal_skeleton_development | 0.74872370 |
| 141 | MP0000163_abnormal_cartilage_morphology | 0.73588327 |
| 142 | MP0001299_abnormal_eye_distance/ | 0.72781939 |
| 143 | MP0003942_abnormal_urinary_system | 0.72763235 |
| 144 | MP0008874_decreased_physiological_sensi | 0.71703707 |
| 145 | MP0002069_abnormal_eating/drinking_beha | 0.71109056 |
| 146 | MP0003632_abnormal_nervous_system | 0.70923820 |
| 147 | MP0001533_abnormal_skeleton_physiology | 0.70069355 |
| 148 | MP0001905_abnormal_dopamine_level | 0.69991314 |
| 149 | MP0003045_fibrosis | 0.69846853 |
| 150 | MP0001529_abnormal_vocalization | 0.69396489 |
| 151 | MP0000428_abnormal_craniofacial_morphol | 0.68736439 |
| 152 | MP0002115_abnormal_skeleton_extremities | 0.68653276 |
| 153 | MP0004742_abnormal_vestibular_system | 0.68416967 |
| 154 | MP0005076_abnormal_cell_differentiation | 0.68044750 |
| 155 | MP0000627_abnormal_mammary_gland | 0.67088690 |
| 156 | MP0010678_abnormal_skin_adnexa | 0.66604387 |
| 157 | MP0005409_darkened_coat_color | 0.66532586 |
| 158 | MP0003795_abnormal_bone_structure | 0.66280636 |
| 159 | MP0005187_abnormal_penis_morphology | 0.65529270 |
| 160 | MP0005367_renal/urinary_system_phenotyp | 0.64574526 |
| 161 | MP0000516_abnormal_urinary_system | 0.64574526 |
| 162 | MP0000920_abnormal_myelination | 0.63766219 |
| 163 | MP0009764_decreased_sensitivity_to | 0.62764739 |
| 164 | MP0000534_abnormal_ureter_morphology | 0.62746865 |
| 165 | MP0008875_abnormal_xenobiotic_pharmacok | 0.62555769 |
| 166 | MP0003195_calcinosis | 0.61700794 |
| 167 | MP0000538_abnormal_urinary_bladder | 0.61542583 |
| 168 | MP0000613_abnormal_salivary_gland | 0.60992336 |
| 169 | MP0000432_abnormal_head_morphology | 0.60756118 |
| 170 | MP0001614_abnormal_blood_vessel | 0.59138423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.82739704 |
| 2 | Premature rupture of membranes (HP:0001788) | 5.61552039 |
| 3 | Myokymia (HP:0002411) | 4.39156924 |
| 4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.31968510 |
| 5 | Protrusio acetabuli (HP:0003179) | 4.24816693 |
| 6 | Focal seizures (HP:0007359) | 4.15664883 |
| 7 | Neurofibrillary tangles (HP:0002185) | 3.91658810 |
| 8 | Atrophic scars (HP:0001075) | 3.90463059 |
| 9 | Aortic dissection (HP:0002647) | 3.81978123 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.74087647 |
| 11 | Interstitial pulmonary disease (HP:0006530) | 3.71594101 |
| 12 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.71009439 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 3.71009439 |
| 14 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.66684435 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.65828099 |
| 16 | Visual hallucinations (HP:0002367) | 3.59892608 |
| 17 | Abnormal ciliary motility (HP:0012262) | 3.57274945 |
| 18 | Rhinitis (HP:0012384) | 3.57032953 |
| 19 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.55133902 |
| 20 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.55133902 |
| 21 | Absence seizures (HP:0002121) | 3.41762800 |
| 22 | Atonic seizures (HP:0010819) | 3.31824603 |
| 23 | Short nail (HP:0001799) | 3.28586501 |
| 24 | Febrile seizures (HP:0002373) | 3.28403248 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.25728256 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.25728256 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.25728256 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.19582331 |
| 29 | Dialeptic seizures (HP:0011146) | 3.08205039 |
| 30 | Mitral stenosis (HP:0001718) | 3.06612249 |
| 31 | Hyperventilation (HP:0002883) | 3.04850401 |
| 32 | Nuclear cataract (HP:0100018) | 2.99875638 |
| 33 | Action tremor (HP:0002345) | 2.99040107 |
| 34 | Cardiovascular calcification (HP:0011915) | 2.98992208 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.98487980 |
| 36 | Spondylolisthesis (HP:0003302) | 2.96349830 |
| 37 | Fragile skin (HP:0001030) | 2.90622203 |
| 38 | Cervical subluxation (HP:0003308) | 2.87493706 |
| 39 | Epileptic encephalopathy (HP:0200134) | 2.87105237 |
| 40 | Abnormality of dentin (HP:0010299) | 2.83742763 |
| 41 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.81617917 |
| 42 | Osteolytic defects of the hand bones (HP:0009699) | 2.81617917 |
| 43 | Absent frontal sinuses (HP:0002688) | 2.78051158 |
| 44 | Progressive cerebellar ataxia (HP:0002073) | 2.71968942 |
| 45 | Tubulointerstitial fibrosis (HP:0005576) | 2.65194094 |
| 46 | Chronic bronchitis (HP:0004469) | 2.61734745 |
| 47 | Aortic aneurysm (HP:0004942) | 2.60537555 |
| 48 | Papilledema (HP:0001085) | 2.54483018 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52797586 |
| 50 | Vertebral compression fractures (HP:0002953) | 2.48327922 |
| 51 | Vascular calcification (HP:0004934) | 2.47679893 |
| 52 | Bladder diverticulum (HP:0000015) | 2.43715409 |
| 53 | Soft skin (HP:0000977) | 2.43528119 |
| 54 | Progressive inability to walk (HP:0002505) | 2.41993933 |
| 55 | Drooling (HP:0002307) | 2.41482003 |
| 56 | Excessive salivation (HP:0003781) | 2.41482003 |
| 57 | Anxiety (HP:0000739) | 2.39734629 |
| 58 | Wormian bones (HP:0002645) | 2.38787675 |
| 59 | Ankle contracture (HP:0006466) | 2.38686784 |
| 60 | Mutism (HP:0002300) | 2.36375629 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36207385 |
| 62 | Nasal polyposis (HP:0100582) | 2.32748839 |
| 63 | Long toe (HP:0010511) | 2.32495695 |
| 64 | Agitation (HP:0000713) | 2.30827946 |
| 65 | Dilatation of the ascending aorta (HP:0005111) | 2.28605148 |
| 66 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.26866783 |
| 67 | Abnormality of binocular vision (HP:0011514) | 2.26482183 |
| 68 | Diplopia (HP:0000651) | 2.26482183 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.26293282 |
| 70 | Bronchiectasis (HP:0002110) | 2.22522423 |
| 71 | Mitral valve prolapse (HP:0001634) | 2.19033523 |
| 72 | Absent speech (HP:0001344) | 2.18558027 |
| 73 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.17511490 |
| 74 | Exotropia (HP:0000577) | 2.16791418 |
| 75 | Bronchomalacia (HP:0002780) | 2.16772792 |
| 76 | Broad-based gait (HP:0002136) | 2.16122960 |
| 77 | Blue irides (HP:0000635) | 2.11481731 |
| 78 | Genu recurvatum (HP:0002816) | 2.10941778 |
| 79 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.10418491 |
| 80 | Shallow orbits (HP:0000586) | 2.09909451 |
| 81 | Truncal ataxia (HP:0002078) | 2.09638317 |
| 82 | Aortic regurgitation (HP:0001659) | 2.08685906 |
| 83 | Megalencephaly (HP:0001355) | 2.08245326 |
| 84 | Inappropriate behavior (HP:0000719) | 2.07456029 |
| 85 | Abnormality of salivation (HP:0100755) | 2.07368112 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.07335044 |
| 87 | Hemiparesis (HP:0001269) | 2.06728830 |
| 88 | Congenital glaucoma (HP:0001087) | 2.05262438 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 2.05129131 |
| 90 | Arterial tortuosity (HP:0005116) | 2.04998163 |
| 91 | Hyperextensible skin (HP:0000974) | 2.04978843 |
| 92 | Glucose intolerance (HP:0000833) | 2.03434530 |
| 93 | Follicular hyperkeratosis (HP:0007502) | 2.03357171 |
| 94 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.02246742 |
| 95 | Aplasia of the phalanges of the hand (HP:0009802) | 2.02246742 |
| 96 | Aplasia involving bones of the extremities (HP:0009825) | 2.02246742 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 2.02146432 |
| 98 | Progressive sensorineural hearing impairment (HP:0000408) | 2.01791048 |
| 99 | Blue sclerae (HP:0000592) | 2.00983107 |
| 100 | Flat acetabular roof (HP:0003180) | 2.00727002 |
| 101 | Tachypnea (HP:0002789) | 1.99853425 |
| 102 | Peritonitis (HP:0002586) | 1.97640991 |
| 103 | Broad metatarsal (HP:0001783) | 1.97092112 |
| 104 | Depression (HP:0000716) | 1.96975064 |
| 105 | Torticollis (HP:0000473) | 1.96453442 |
| 106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.95975956 |
| 107 | Amyloidosis (HP:0011034) | 1.93603010 |
| 108 | Spinal rigidity (HP:0003306) | 1.93257682 |
| 109 | Neonatal short-limb short stature (HP:0008921) | 1.92577480 |
| 110 | Upper limb amyotrophy (HP:0009129) | 1.92122875 |
| 111 | Distal upper limb amyotrophy (HP:0007149) | 1.92122875 |
| 112 | Overgrowth (HP:0001548) | 1.91907605 |
| 113 | Turricephaly (HP:0000262) | 1.91803501 |
| 114 | Axonal loss (HP:0003447) | 1.90575265 |
| 115 | Amblyopia (HP:0000646) | 1.89487124 |
| 116 | Stereotypic behavior (HP:0000733) | 1.88258621 |
| 117 | Mitral regurgitation (HP:0001653) | 1.87405548 |
| 118 | Vascular tortuosity (HP:0004948) | 1.86641234 |
| 119 | Buphthalmos (HP:0000557) | 1.86545134 |
| 120 | Natal tooth (HP:0000695) | 1.85406569 |
| 121 | Ankyloglossia (HP:0010296) | 1.85191268 |
| 122 | Myocardial infarction (HP:0001658) | 1.84720734 |
| 123 | Spinal cord compression (HP:0002176) | 1.83712243 |
| 124 | Psychosis (HP:0000709) | 1.82799910 |
| 125 | Abnormality of the acetabulum (HP:0003170) | 1.82615696 |
| 126 | Elbow flexion contracture (HP:0002987) | 1.82244789 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.81359654 |
| 128 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81359654 |
| 129 | Postural instability (HP:0002172) | 1.80170148 |
| 130 | Clumsiness (HP:0002312) | 1.79166275 |
| 131 | Thin bony cortex (HP:0002753) | 1.79100431 |
| 132 | Mixed hearing impairment (HP:0000410) | 1.79070864 |
| 133 | Hyperactive renin-angiotensin system (HP:0000841) | 1.78761323 |
| 134 | Status epilepticus (HP:0002133) | 1.78751578 |
| 135 | Dementia (HP:0000726) | 1.78113291 |
| 136 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.77986407 |
| 137 | Tetraparesis (HP:0002273) | 1.77102873 |
| 138 | Facial shape deformation (HP:0011334) | 1.76559738 |
| 139 | Potter facies (HP:0002009) | 1.76559738 |
| 140 | Resting tremor (HP:0002322) | 1.76452618 |
| 141 | Generalized hypopigmentation of hair (HP:0011358) | 1.76300659 |
| 142 | Hand muscle atrophy (HP:0009130) | 1.75058740 |
| 143 | Glomerulonephritis (HP:0000099) | 1.74379922 |
| 144 | Abnormal social behavior (HP:0012433) | 1.74294141 |
| 145 | Impaired social interactions (HP:0000735) | 1.74294141 |
| 146 | Broad face (HP:0000283) | 1.74238294 |
| 147 | Abnormality of carpal bone ossification (HP:0006257) | 1.74029838 |
| 148 | Abnormality of macrophages (HP:0004311) | 1.73147685 |
| 149 | Widely spaced teeth (HP:0000687) | 1.73069519 |
| 150 | Onycholysis (HP:0001806) | 1.72673702 |
| 151 | Protruding tongue (HP:0010808) | 1.71956319 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71943516 |
| 153 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71943516 |
| 154 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71943516 |
| 155 | Termporal pattern (HP:0011008) | 1.71731921 |
| 156 | Insidious onset (HP:0003587) | 1.71731921 |
| 157 | Ulnar bowing (HP:0003031) | 1.71547933 |
| 158 | Ovoid vertebral bodies (HP:0003300) | 1.71350427 |
| 159 | Cerebral aneurysm (HP:0004944) | 1.69595197 |
| 160 | Rapidly progressive (HP:0003678) | 1.68972693 |
| 161 | Hyperkalemia (HP:0002153) | 1.68274824 |
| 162 | Femoral bowing (HP:0002980) | 1.67886460 |
| 163 | Apathy (HP:0000741) | 1.66633885 |
| 164 | Cerebral hemorrhage (HP:0001342) | 1.66529141 |
| 165 | Hyperparathyroidism (HP:0000843) | 1.65787126 |
| 166 | Abnormal ossification of hand bones (HP:0005921) | 1.65314508 |
| 167 | Retinal atrophy (HP:0001105) | 1.64617371 |
| 168 | Hypoventilation (HP:0002791) | 1.64315519 |
| 169 | Synostosis involving the elbow (HP:0003938) | 1.64125031 |
| 170 | Humeroradial synostosis (HP:0003041) | 1.64125031 |
| 171 | Abnormal eating behavior (HP:0100738) | 1.64097456 |
| 172 | Bowel diverticulosis (HP:0005222) | 1.63858707 |
| 173 | Aneurysm (HP:0002617) | 1.63854740 |
| 174 | Eczematoid dermatitis (HP:0000976) | 1.63776498 |
| 175 | Thickened helices (HP:0000391) | 1.62643209 |
| 176 | Tubulointerstitial abnormality (HP:0001969) | 1.62519383 |
| 177 | Loss of speech (HP:0002371) | 1.61800344 |
| 178 | Joint stiffness (HP:0001387) | 1.61706725 |
| 179 | Protuberant abdomen (HP:0001538) | 1.61657818 |
| 180 | Joint laxity (HP:0001388) | 1.61247746 |
| 181 | Dysmetria (HP:0001310) | 1.61104279 |
| 182 | Abnormality of the frontal sinuses (HP:0002687) | 1.61082627 |
| 183 | Progressive hearing impairment (HP:0001730) | 1.59892413 |
| 184 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.59595497 |
| 185 | Postural tremor (HP:0002174) | 1.59586128 |
| 186 | Osteoarthritis (HP:0002758) | 1.59139511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.89299061 |
| 2 | NTRK3 | 3.69180083 |
| 3 | RIPK4 | 3.63276623 |
| 4 | EPHA2 | 3.27411473 |
| 5 | MAP3K9 | 2.94105732 |
| 6 | IRAK3 | 2.74013170 |
| 7 | DDR2 | 2.66678245 |
| 8 | TRPM7 | 2.60575282 |
| 9 | NEK9 | 2.55096921 |
| 10 | DAPK2 | 2.51957022 |
| 11 | LATS2 | 2.43852766 |
| 12 | TESK1 | 2.36300192 |
| 13 | MET | 2.29456958 |
| 14 | NTRK1 | 2.29284977 |
| 15 | MAP3K2 | 2.23019607 |
| 16 | MAP3K13 | 2.08498432 |
| 17 | MOS | 2.08256184 |
| 18 | MAPK15 | 2.05583647 |
| 19 | MAP3K12 | 2.04788828 |
| 20 | LIMK1 | 2.03452347 |
| 21 | CASK | 2.00308028 |
| 22 | MAP3K4 | 1.98019953 |
| 23 | SCYL2 | 1.93593075 |
| 24 | KSR2 | 1.92489917 |
| 25 | TGFBR2 | 1.89622820 |
| 26 | MYLK | 1.87525674 |
| 27 | LATS1 | 1.86636272 |
| 28 | TTN | 1.85802692 |
| 29 | MINK1 | 1.84602343 |
| 30 | MAP2K7 | 1.70820112 |
| 31 | MAP3K3 | 1.63557238 |
| 32 | PAK4 | 1.60316389 |
| 33 | ARAF | 1.56020745 |
| 34 | MAP2K4 | 1.53281114 |
| 35 | PLK2 | 1.53002914 |
| 36 | FES | 1.42859815 |
| 37 | GRK5 | 1.41166744 |
| 38 | PAK2 | 1.38855181 |
| 39 | MARK1 | 1.35458438 |
| 40 | BMPR2 | 1.34849676 |
| 41 | NTRK2 | 1.34276910 |
| 42 | FRK | 1.33500210 |
| 43 | ICK | 1.30159674 |
| 44 | CAMKK2 | 1.27472279 |
| 45 | FER | 1.26418309 |
| 46 | EPHB2 | 1.21325590 |
| 47 | CAMKK1 | 1.20288479 |
| 48 | STK38L | 1.20080471 |
| 49 | NME2 | 1.20061129 |
| 50 | KSR1 | 1.19753168 |
| 51 | STK10 | 1.19563739 |
| 52 | MAP3K14 | 1.19003121 |
| 53 | ROCK2 | 1.15875709 |
| 54 | PRKD3 | 1.15291725 |
| 55 | SIK2 | 1.14123649 |
| 56 | CDC42BPA | 1.11549335 |
| 57 | CDK5 | 1.09635922 |
| 58 | PRKCE | 1.05952642 |
| 59 | TRIB3 | 1.05925356 |
| 60 | STK24 | 1.05345543 |
| 61 | FGR | 1.05233059 |
| 62 | SGK2 | 1.03734976 |
| 63 | FGFR2 | 1.03373802 |
| 64 | ERBB3 | 1.01053931 |
| 65 | ABL2 | 0.98558235 |
| 66 | DAPK1 | 0.93680872 |
| 67 | MAP3K1 | 0.92433140 |
| 68 | BCR | 0.92124790 |
| 69 | SIK1 | 0.91900732 |
| 70 | PTK2B | 0.90372590 |
| 71 | SGK3 | 0.88108786 |
| 72 | SGK494 | 0.87777884 |
| 73 | SGK223 | 0.87777884 |
| 74 | CAMK2A | 0.87683848 |
| 75 | RET | 0.85409987 |
| 76 | CAMK1G | 0.85133980 |
| 77 | EPHA3 | 0.85058745 |
| 78 | PAK6 | 0.83146754 |
| 79 | EPHB1 | 0.81996370 |
| 80 | SGK1 | 0.81855681 |
| 81 | PRKCH | 0.81301812 |
| 82 | LMTK2 | 0.78986505 |
| 83 | GRK7 | 0.78591285 |
| 84 | ROCK1 | 0.77882544 |
| 85 | PIM2 | 0.74606629 |
| 86 | ERN1 | 0.74144540 |
| 87 | SIK3 | 0.72495991 |
| 88 | MAP2K1 | 0.72470384 |
| 89 | WNK1 | 0.70532938 |
| 90 | CDK6 | 0.70345528 |
| 91 | AKT3 | 0.69171941 |
| 92 | MST1R | 0.67729173 |
| 93 | STK3 | 0.67340477 |
| 94 | DMPK | 0.67149877 |
| 95 | PRKCG | 0.66418732 |
| 96 | RIPK1 | 0.66407747 |
| 97 | CAMK2B | 0.66407000 |
| 98 | FGFR3 | 0.65455323 |
| 99 | PAK3 | 0.65310815 |
| 100 | PBK | 0.63326093 |
| 101 | PDGFRB | 0.62397911 |
| 102 | JAK1 | 0.62140498 |
| 103 | TAOK3 | 0.61906087 |
| 104 | FYN | 0.61801864 |
| 105 | PRKD2 | 0.61728558 |
| 106 | WNK4 | 0.61120342 |
| 107 | GSK3A | 0.58524868 |
| 108 | PDPK1 | 0.58297632 |
| 109 | MTOR | 0.56322830 |
| 110 | TAOK2 | 0.55583348 |
| 111 | ERBB4 | 0.55020367 |
| 112 | MAPK13 | 0.54867633 |
| 113 | TBK1 | 0.53203485 |
| 114 | EGFR | 0.52868379 |
| 115 | PRKCZ | 0.52646037 |
| 116 | CSNK1G2 | 0.51280849 |
| 117 | MELK | 0.51274845 |
| 118 | TNIK | 0.50851409 |
| 119 | RPS6KA2 | 0.50348679 |
| 120 | PRKCQ | 0.49491070 |
| 121 | IKBKE | 0.49468126 |
| 122 | PDGFRA | 0.48361629 |
| 123 | FLT3 | 0.47579796 |
| 124 | BMPR1B | 0.45201523 |
| 125 | STK38 | 0.44757065 |
| 126 | RAF1 | 0.44286000 |
| 127 | MST4 | 0.44268683 |
| 128 | CAMK2D | 0.42618894 |
| 129 | MAP3K6 | 0.42344606 |
| 130 | ILK | 0.42229356 |
| 131 | CAMK2G | 0.41036629 |
| 132 | LRRK2 | 0.40777815 |
| 133 | SRC | 0.40577487 |
| 134 | PKN2 | 0.39199029 |
| 135 | INSRR | 0.38805215 |
| 136 | BMX | 0.38388422 |
| 137 | PNCK | 0.38304169 |
| 138 | CHUK | 0.37773158 |
| 139 | ADRBK1 | 0.37759450 |
| 140 | TAOK1 | 0.37495058 |
| 141 | PTK2 | 0.37449610 |
| 142 | JAK2 | 0.35836092 |
| 143 | PTK6 | 0.34633506 |
| 144 | INSR | 0.34540077 |
| 145 | ADRBK2 | 0.34491358 |
| 146 | ERBB2 | 0.34459657 |
| 147 | CAMK1 | 0.33758201 |
| 148 | DYRK1A | 0.33490028 |
| 149 | STK39 | 0.33424741 |
| 150 | CAMK1D | 0.33399738 |
| 151 | EIF2AK3 | 0.33096125 |
| 152 | FGFR4 | 0.32434196 |
| 153 | MAPKAPK3 | 0.31808550 |
| 154 | EEF2K | 0.31737051 |
| 155 | ABL1 | 0.31262797 |
| 156 | YES1 | 0.29657285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.53481357 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.47177930 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.33193107 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.32188216 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.24535951 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.07898825 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.03554807 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.96470223 |
| 9 | Focal adhesion_Homo sapiens_hsa04510 | 1.93600764 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.91796579 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.81184960 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.79727917 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.79431591 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.76400604 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.75448266 |
| 16 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.72132105 |
| 17 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.70821365 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.68043416 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.60687503 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.59978498 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.57525847 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.52874670 |
| 23 | Adherens junction_Homo sapiens_hsa04520 | 1.51970056 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43797121 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.43422715 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.41323197 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40713927 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38021360 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.36520206 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.35689735 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.34990283 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34669342 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34306380 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.33740862 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33343042 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33012337 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32606951 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31983830 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28932003 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.27303109 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24977537 |
| 42 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.19010586 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18046056 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17701479 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.15113941 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13539209 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.13023992 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08267726 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.07311071 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05299213 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.03891490 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03666704 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02826617 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00795201 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00576604 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99173143 |
| 57 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.96966921 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 0.96750584 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94383841 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.94090445 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93650988 |
| 62 | Tight junction_Homo sapiens_hsa04530 | 0.92472014 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 0.92461521 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92460253 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90548433 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.89605805 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89578539 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89290949 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89131094 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.88238655 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88033570 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87659872 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.86425879 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.86350417 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85203999 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84603684 |
| 77 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83685801 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83110730 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.82722023 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82085565 |
| 81 | Melanogenesis_Homo sapiens_hsa04916 | 0.81987678 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81153635 |
| 83 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.80765192 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78538787 |
| 85 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.77630863 |
| 86 | Melanoma_Homo sapiens_hsa05218 | 0.76470463 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76174317 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75604692 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74915787 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74273391 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72586284 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72569307 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72389556 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72364984 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71976988 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71837009 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71671126 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70925206 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70292978 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.68342244 |
| 101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67598935 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.67156319 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66439798 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64522760 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64306066 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64236504 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63211472 |
| 108 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.62743185 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.61491945 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61118442 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60390236 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60316620 |
| 113 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59697687 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58740975 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58558334 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.58187788 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56895586 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55273289 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54709352 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51679329 |
| 121 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50869092 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50488594 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50435996 |
| 124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50416480 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50135265 |
| 126 | Bile secretion_Homo sapiens_hsa04976 | 0.49689505 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49189489 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.48533167 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48228927 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48198665 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48089718 |
| 132 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47746927 |
| 133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47485067 |
| 134 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46995431 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46739001 |
| 136 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45737235 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45278003 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.45007530 |
| 139 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44975985 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43780562 |
| 141 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43739105 |
| 142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42995846 |
| 143 | Hepatitis B_Homo sapiens_hsa05161 | 0.42074018 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.40598720 |
| 145 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40000099 |
| 146 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39663794 |
| 147 | Platelet activation_Homo sapiens_hsa04611 | 0.38844877 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38371453 |
| 149 | Allograft rejection_Homo sapiens_hsa05330 | 0.38270224 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37971729 |
| 151 | Hepatitis C_Homo sapiens_hsa05160 | 0.37140816 |
| 152 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36954624 |

